Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaimini Patoliya has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Uncovering the Interaction Interface Between Harpin (Hpa1) and Rice Aquaporin (OsPIP1;3) Through Protein–Protein Docking: An In Silico Approach

    by Jaimini Patoliya, Khushali Thaker, Khushbu Rabadiya, Dhaval Patel, Nayan K. Jain, Rushikesh Joshi

    Hpa1 (a type of harpin) is involved in T3SS (Type III Secretion System) assembly in the infection mechanism by Xanthomonas Oryzae pv. oryzae (Xoo). Hpa1 interacts with the plasma membrane components of plants thereby assisting effector proteins toward the cytoplasm, wherein effectors execute their pathological functions. Independently, harpins also induce hypersensitive response and systemic acquired resistance in plants. However, lack of knowledge regarding the plant–harpin interaction mechanism constrains the pathway of its agricultural application. Although an in vitro study proved that Hpa1 protein can interact with OsPIP1;3, a rice aquaporin, the structural basis of the interaction is yet to be discovered. The presented work is the first of its kind where an in silico approach is used for the PPI (protein–protein interaction) of harpin protein. The study discovered participation of Hpa1 N-terminal amino acids at the interface. Besides, MD simulation studies were performed to assess the stability. RMSD values were 0.35 ± 0.049, 0.73 ± 0.11, and 0.50 ± 0.065 nm for OsPIP1;3, Hpa1, and Hpa1-OsPIP1;3 complex, respectively. Additionally, Residue-wise fluctuations have also been studied post-MDS. Taken together, these findings not only give a solid foundation for a deeper knowledge of various interacting target molecules with Harpin protein orthologs but also bring a new avenue for the structural–functional relationship study of harpin proteins.


  • Open Access

    IN-VITRO STUDY OF Α- GLUCOSIDASE INHIBITION ACTIVITY OF ALSTONIA SCHOLARIS AND CATHARANTHUS ROSEUS

    by Khushali Thaker, Jaimini Patoliya, Khushbu Rabadiya, Zankruti Dholakia, Rushikesh Joshi

    The increasing population of Diabetes Mellitus (DM) in the world has always been concerned by physicians and scientists due to its life-threatening effects including heart diseases and premature death. Out of them, nearly 90-95% population is having type 2 diabetes mellitus (T2DM), characterised by insulin resistance. The available treatments for T2DM includes inhibition of α- glucosidase present on the brush border of human intestine that controls post-prandial hyperglycaemia by slower the releasing of glucose in the blood. Adverse effects of the available α- glucosidase inhibitors (AGI) such as abdominal discomfort and hypoglycaemia has prompted a search for the newer AGIs from natural compounds. The impact of various plant extracts on the management of medical disorders has recently aroused curiosity of researchers. Alstonia scholaris has set its hight reputation in ethnopharmacological world for treating major health issues including skin carcinoma, lung cancer and also T2DM. Though some research supports the antidiabetic activity of the plant, the mode of action responsible for it has yet to be discovered. At the same time, Catharanthus roseus has also been proved to be effective in diabetic conditions but in vitro study of antidiabetic activity of the plant is yet to be encountered. The presented study investigated different extracts of A. scholaris and C. roseus on α- glucosidase isolated from Saccharomyces cerevisiae. The presented research not only gives in-vitro proves of the plants as AGIs but also open ups new pathways in understanding the secondary metabolites as inhibitors.